Dr. Sweetman shares how COMISA care can improve with strategic GP education, cross-specialty collaboration and increased CBT-I access.
Dr. Sweetman explores how reimbursement gaps and workforce shortages drive over-reliance on medication over CBT-I in insomnia care.
Dr. Sweetman explores new insomnia and COMISA treatments and shares his future research path toward better COMISA care access and delivery.
OSA is chronic and affects nearly a billion people, yet care remains rigid and binary. It’s time for a model that’s flexible and supports ...
Professor Grote discusses the role of national and European registries in advancing sleep apnea care.
Professor Grote explains how symptoms and comorbidities are evaluated within the context of the Swedish treatment matrix.
Professor Grote reflects on the clinical reception, implementation and impact of the Swedish OSA treatment matrix since its 2021 rollout.
Professor Grote discusses how involving general practitioners more directly in OSA care could help improve access to timely OSA care.
Professor Grote sheds light on the rising demand for OSA treatment and the attendant strain on health systems.
OSA is a prevalent yet underdiagnosed disease, currently affecting over 50 million adults in the United States, yet up to 80% of cases ...
By reducing acute care costs and improving management of high-cost comorbidities, PAP therapy offers a compelling opportunity to reduce ...
Immediate action is needed by multiple sleep stakeholders to ensure the future burden of OSA can be clinically managed by sleep specialists ...
Hear from Dr. Jonna Morris about diagnostic and screening blind spots surrounding women and OSA.
Dr. Jonna Morris explains how language and reporting patterns affect OSA presentation in women, and why many remain overlooked.
Making sleep essential requires more than recognition—it demands policy, funding, and clinical integration across systems of care.
Recognizing sleep as essential marks progress, but real-world change in care delivery, education, and funding remains critically overdue.
Hear from Prof. Winfried Randerath about the adoption of the Baveno classification into clinical practice and the role of primary care in ...
Hear from Prof. Winfried Randerath what impact the modified Baveno classification has for women, people with mild OSA and others.
Hear from Prof. Winfried Randerath how and why AHI has been added to the modified Baveno classification and its impact on patients.
Hear from Prof. Winfried Randerath how the Baveno classification has been modified to more effectively categorize patients with sleep apnea.
Along with the economy, productivity and health systems, we must invest in rest as a serious policy principle. It is that integral to our ...
AHI as the sole or primary OSA diagnostic criteria puts too many people at risk by preventing treatment for those who need it.
The AHI and OSA are deeply intertwined, but questions have been asked about AHI as a metric of OSA diagnosis and classification from the ...
A growing body of research shows how gender biases and stereotypes of obstructive sleep apnea stand in the way of women receiving the help ...
Despite clear recognition as a standalone condition, COMISA remains not only underdiagnosed but poorly managed, falling through many ...
Clinicians, policymakers and industry leaders must give greater attention to the impact of COMISA on individuals, health systems and ...
As comorbid insomnia and OSA (COMISA) is recognized as a standalone condition, diagnostic approaches lack, resulting in high rates of ...
CBT-I ushers in a new level of promise for patients with insomnia as a true treatment that is non-invasive and free of pharmacological ...
Current approaches to OSA leave many struggling, often going undiagnosed and untreated. A P4 mindset can shift thinking to identify at-risk ...
RWE with RCTs blends theory with practice to increase patient representation and identify long-term trends, enhancing the ability to ...
Privacy|Terms of use |©2025 Resmed|All rights reserved
